Every Form 4 that Octave Specialty Group, Inc. (OSG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow OSG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OSG filings page.
Octave Specialty Group Inc. Chief Executive Officer Claude LeBlanc reported equity compensation activity tied to his 2025 Long Term Incentive Plan. On July 9, 2026, 39,380 restricted stock units vested and were converted into common shares, with 21,777 shares withheld by the company at $6.08 per share to cover tax obligations. Following these transactions, LeBlanc holds 1,065,234 shares of common stock directly and 480,832 restricted stock units that remain outstanding and subject to future vesting through July 2028.
Octave Specialty Group Inc. executive Sharon R. Smith, Exec VP & Group COO, acquired common stock through the vesting and settlement of 11,779 Restricted Stock Units (RSUs) under her 2025 Long Term Incentive Plan. To cover tax obligations, 4,635 of the resulting shares were withheld by the company. Following these transactions, she holds 156,326 shares of common stock directly and 132,093 RSUs, which continue to vest in three equal annual installments on July 9, 2026, July 9, 2027, and July 9, 2028.
Octave Specialty Group Inc. executive vice president, CFO and treasurer David Trick reported routine equity compensation activity tied to his 2025 Long Term Incentive Plan. On July 9, 2026, 13,206 Restricted Stock Units vested and were settled into common shares, and 6,741 shares were withheld by the company at $6.08 per share to satisfy tax withholding obligations. Following these transactions, Trick directly holds 267,096 shares of common stock and 124,978 RSUs. The RSU award vests in three equal annual installments on July 9, 2026, July 9, 2027, and July 9, 2028.
Octave Specialty Group Inc. director Jeffrey Scott Stein received a grant of 6,500 restricted stock units (RSUs) linked to the company’s common stock. Each RSU represents a contingent right to receive one share of common stock, providing equity-based compensation rather than cash.
The RSUs were granted on July 1, 2026 and are scheduled to vest one year later on July 1, 2027. Once vested, they will convert into common shares when Stein leaves the Board of Directors or if a change of control of the company occurs. After this grant, his reported direct RSU holdings total 22,591 units.
Octave Specialty Group director Michael D. Price received a grant of 6,500 restricted stock units (RSUs) on July 1, 2026. Each RSU represents a contingent right to one share of common stock at no purchase price. These RSUs vest on July 1, 2027 and will convert into shares when he leaves the Board or if there is a change of control of the company. Following this grant, he directly holds 22,591 RSUs tied to Octave Specialty Group common stock.
Matus Kristi Ann reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group Inc director Kristi Ann Matus received a grant of 6,500 Restricted Stock Units (RSUs) on July 1, 2026. Each RSU represents a contingent right to receive one share of common stock. Following this award, she holds 22,591 shares-related units directly.
The RSUs granted on July 1, 2026 will vest on July 1, 2027. Once vested, they will settle into common shares when she leaves the Board of Directors or if there is a change of control of the company.
Octave Specialty Group Inc director Joan M. LammTennant received a grant of 6,500 Restricted Stock Units on July 1, 2026. Each RSU represents a contingent right to one share of common stock. After this award, she holds 22,591 RSUs directly.
The RSUs granted on July 1, 2026 are scheduled to vest on July 1, 2027. Once vested, they will convert into common shares when she leaves the Board of Directors or if there is a change of control at the company.
Octave Specialty Group director Lisa G. Iglesias received a grant of 6,500 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Octave Specialty Group, Inc. common stock. Following this award, her reported direct RSU holdings increased to 22,591 units.
The RSUs granted on July 1, 2026 will vest on July 1, 2027. Once vested, they convert into common shares upon the earlier of the vesting date, the date she leaves the Board of Directors, or a change of control of the company. This is a compensation-related, non-cash equity award rather than an open-market stock purchase or sale.
Octave Specialty Group Inc. director Ian David Haft received a grant of 6,500 restricted stock units on July 1, 2026. Each RSU represents a contingent right to one share of common stock. The RSUs vest on July 1, 2027 and will convert into shares when he leaves the Board. Following this grant, Haft holds 22,591 common-share-equivalent units directly.
Stein Jeffrey Scott reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group Inc. director Jeffrey Scott Stein received a grant of 7,441 restricted stock units (RSUs). The RSUs were granted on April 1, 2026 and each RSU represents a contingent right to receive one share of Octave Specialty Group common stock.
The RSUs are scheduled to vest on April 1, 2027. Vested RSUs will settle into common shares on the earlier of the vesting date or when Stein ceases to be a member of the Board of Directors, unless he elects to defer settlement. Following this award, he holds 16,091 RSUs directly.
HAFT IAN DAVID reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group Inc. director Ian David Haft received a grant of 7,441 restricted stock units (RSUs). The award was made on April 1, 2026 and increases his directly held RSUs to 16,091. Each RSU represents a contingent right to receive one share of Octave Specialty Group common stock.
These RSUs are scheduled to vest on April 1, 2027. Once vested, they will settle into common shares on the vesting date or when Haft ceases to be a member of the Board of Directors, unless he elects to defer settlement.
IGLESIAS LISA G reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group director Lisa G. Iglesias received a grant of 7,441 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the company’s common stock. Following this award, her directly held equity-linked interest totals 16,091 shares.
The RSUs were granted on April 1, 2026 and are scheduled to vest one year later on April 1, 2027. Vested RSUs will settle into common shares on the vesting date or when she ceases to serve on the Board of Directors, unless she elects to defer settlement.
Octave Specialty Group director Joan M. LammTennant received a grant of 7,441 restricted stock units (RSUs), each representing a contingent right to one share of common stock.
The RSUs were granted on April 1, 2026 and are scheduled to vest on April 1, 2027. Vested RSUs will convert into common shares on the earlier of the vesting date or when she ceases to serve on the Board, unless she elects to defer settlement. Following this award, she directly holds 16,091 RSUs tied to Octave Specialty Group common stock.
Matus Kristi Ann reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group Inc. director Kristi Ann Matus received a grant of 7,441 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the company’s common stock. Following this grant, she holds 16,091 RSUs directly.
The RSUs granted on April 1, 2026 are scheduled to vest on April 1, 2027. Once vested, they will settle into common shares on the earlier of the vesting date or the date she ceases to serve on the Board of Directors, subject to any deferral election.
Octave Specialty Group director Michael D. Price received a grant of restricted stock units as equity compensation. On April 1, 2026, he was awarded 7,441 RSUs, each representing a right to receive one share of common stock. Following this award, his directly held RSUs total 16,091.
The RSUs granted on April 1, 2026 are scheduled to vest on April 1, 2027. Vested RSUs will convert into common shares on the earlier of the vesting date or when he ceases to serve on the Board of Directors, subject to any deferral election.
Octave Specialty Group’s Chief Accounting Officer, Cristina E. Ahn, reported routine equity compensation activity and tax withholding transactions. On March 23, 2026, she received a grant of 8,067 restricted stock units (RSUs) as part of her 2026 Long Term Incentive Plan award, bringing her RSU holdings to 9,718.
Footnotes state each RSU represents a right to receive one share of common stock, vesting in three equal annual installments starting on March 23, 2027, then on March 23, 2028 and March 23, 2029. On March 10, 2026, 835 RSUs were settled into 835 shares of common stock, and 203 shares were withheld at $4.90 per share to cover tax obligations, leaving 632 common shares directly held after withholding.
Smith R Sharon reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group Inc reported that Executive Vice President and Group COO Sharon R. Smith received a grant of 24,375 restricted stock units as part of her 2026 Long Term Incentive Plan award. Each unit represents a right to receive one share of common stock.
The RSUs vest in three equal annual installments on March 23, 2027, March 23, 2028, and March 23, 2029. Following this award, her reported holdings of this derivative security total 120,314 units, reflecting ongoing equity-based compensation tied to long-term company performance.
Trick David reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group Inc. executive vice president, CFO and treasurer David Trick received a grant of 26,250 restricted stock units (RSUs) on March 23, 2026 as part of his 2026 Long Term Incentive Plan award. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest in three equal annual installments on March 23 of 2027, 2028 and 2029. After this award, Trick directly holds 138,184 shares or share-equivalent units in the company.
METZ LAWRENCE F. reported acquisition or exercise transactions in this Form 4 filing.
Octave Specialty Group Inc. reported that officer Lawrence F. Metz received a grant of 28,246 restricted stock units as part of his 2026 Long Term Incentive Plan award. Each RSU represents a right to receive one share of common stock. The RSUs vest in three equal annual installments on March 23, 2027, March 23, 2028, and March 23, 2029, aligning compensation with long-term company performance.
Octave Specialty Group Inc.'s Chief Executive Officer Claude LeBlanc reported equity award activity on March 3, 2026. He acquired 47,130 Restricted Stock Units (RSUs) upon vesting of portions of his 2023 and 2024 RSU awards, each RSU representing one share of common stock.
On the same date, 22,582 RSUs were converted into an equivalent number of Deferred Share Units (DSUs) under the company’s Executive Stock Deferral Plan, allowing him to defer settlement and income taxation. In addition, 24,548 shares of common stock were acquired through derivative conversion, while 10,694 shares of common stock were withheld by the company at $5.60 per share to cover tax obligations.
Octave Specialty Group executive David Trick reported equity award activity involving restricted and deferred stock units. On March 3, 2026, he acquired 11,505 shares through the exercise and settlement of restricted stock units and 9,790 deferred share units, each representing one share of common stock.
He also acquired 1,715 shares of common stock upon RSU vesting and simultaneously disposed of 1,715 shares at $5.60 per share to satisfy tax withholding obligations. After these transactions, his directly held common stock position increased to 260,631 shares.
Octave Specialty Group executive R. Sharon Smith reported equity award settlements and related tax withholding. Smith acquired 10,261 shares of common stock through vesting of 2023 and 2024 restricted stock unit (RSU) awards, with 8,720 RSUs converted into deferred share units under the company’s executive stock deferral plan. A further 1,541 common shares were issued and the same number immediately withheld at $5.60 per share to cover tax obligations, leaving direct holdings of 149,182 common shares, 95,939 RSUs and 67,486 deferred share units.
Octave Specialty Group Inc. reported a new equity award to one of its directors. On January 1, 2026, the director received 4,524 restricted stock units (RSUs), each representing a right to receive one share of Octave Specialty Group common stock. The RSUs were recorded at an exercise price of $0 and are held as direct beneficial ownership, bringing the director’s total derivative securities beneficially owned to 8,650.
The RSUs granted on January 1, 2026 are scheduled to fully vest on January 1, 2027. Once vested, they convert into shares of common stock on the vesting date or when the director leaves the Board, unless the director has elected to defer settlement.
Octave Specialty Group Inc. director reports new equity award. A board member of Octave Specialty Group Inc. recorded a grant of 4,524 restricted stock units (RSUs) effective January 1, 2026. Each RSU represents a contingent right to receive one share of the company’s common stock.
The RSUs are scheduled to vest on January 1, 2027. Once vested, they will convert into shares of common stock on the earlier of the vesting date or the date the director leaves the company’s Board of Directors, subject to any deferral election by the reporting person. Following this transaction, the filing shows 8,650 derivative securities beneficially owned on a direct basis.
Octave Specialty Group Inc. director reported receiving restricted stock units that could convert into common shares. On January 1, 2026, the reporting person was granted 4,524 restricted stock units (RSUs), each tied to one share of Octave Specialty Group Inc. common stock. The RSUs are listed with a price of $0 and are shown as a direct holding.
The filing states that these RSUs will vest on January 1, 2027. Once vested, they will settle into shares of common stock on the earlier of the vesting date or the date the director resigns from, or otherwise ceases to be a member of, the company’s Board of Directors, unless the director elects to defer settlement. After this transaction, the filing shows 8,650 derivative securities beneficially owned.
Octave Specialty Group Inc. reported an equity award to a board member. On January 1, 2026, the director received 4,524 restricted stock units (RSUs), each representing a contingent right to one share of Octave Specialty Group common stock. These RSUs are scheduled to vest on January 1, 2027, and any vested RSUs will convert into common shares on the earlier of the vesting date or when the director leaves the Board, unless the director elects to defer settlement. After this grant, the director beneficially owns 8,650 derivative securities in the form of RSUs.
Octave Specialty Group Inc. reported an equity award to a board member in the form of restricted stock units. On January 1, 2026, the director received 4,524 restricted stock units (RSUs), each representing a contingent right to receive one share of Octave Specialty Group common stock. These RSUs are scheduled to vest on January 1, 2027. Once vested, they will convert into common shares on the earlier of the vesting date or the date the director leaves the company’s Board of Directors, unless the director elects to defer settlement. After this grant, the reporting person held a total of 8,650 derivative securities related to the company’s stock in direct ownership.
Octave Specialty Group Inc. reported an equity grant to a board member. A director received 4,524 restricted stock units (RSUs) of Octave Specialty Group Inc. common stock on January 1, 2026. Each RSU represents a right to receive one share of common stock and was granted at a price of $0 per unit. The RSUs are scheduled to vest on January 1, 2027. Once vested, they will convert into common shares on the earlier of the vesting date or the date the director ceases to serve on the company’s Board of Directors, unless the director elects to defer settlement. Following this grant, the reporting person holds 8,650 derivative securities directly.
Octave Specialty Group Inc. director and Chief Executive Officer reported buying additional company stock. On 01/02/2026, a Form 4 shows an open-market purchase of 12,000 shares of common stock at a price of $7.59 per share, coded as an acquisition transaction. After this trade, the reporting person beneficially owns 1,033,777 shares of Octave Specialty Group Inc. common stock in direct ownership. The filing reflects a single, straightforward insider purchase with no derivative securities activity disclosed.